Leading in Cardiovascular
Tissue Engineering
We are a biotechnology company focussing on the development and manufacturing of biological medical devices. Our cell-free implants minimize the need for long-term medication, which helps to reduce possible negative side effects. This can significantly improve the quality of life, especially for younger patients.
More Than
0
Years in Business
Available in
0
Countries
More than
14000
Implants Worldwide
Technology
Auto Tissue Berlin uses a proprietary and patented glutaraldehyde-free process to decellularize and sterilize the biological tissue. Decellularized tissue has repeatedly proven to be superior to glutaraldehyde-treated tissue in terms of durability, especially in children.
Contract Manufacturing
Auto Tissue Berlin also offers contract research and manufacturing services for all types of biological tissue, and supports engineering, design and prototyping of cardiovascular devices.
Products
The Matrix Patch™ is a cell-free equine pericardial patch for vascular reconstruction and cardiac defect repair. It is primarily used in pediatric cardiac surgery and for valve repair in adults.
Latest News
August 28, 2022
New Dealer in Mexico
Mike Krüll from MKJ-Trade is the new dealer for Auto Tissue Berlin in Mexico.
August 13, 2022
New video: Tricuspid valve patch augmentation with annular detachment in thin leaflet valves
Dr. Amirghofran from Faghihi Hospital Shiraz published a video case report on CTSNet.
May 12, 2022
ProFIT project: Automatic preservation of human tissue for clinical use
Auto Tissue Berlin has been researching the automation of decellularization since the beginning of 2021 thanks to a positive decision of the Berlin Senate.